Skip to Content
 
Center for International Blood and Marrow Transplant Research

P-6397

Main Content

Return to Listing

Bone Marrow Transplantation | 2026

Clinical risk factors alone do not predict the development of moderate-severe chronic graft-versus-host disease after hematopoietic cell transplantation and post-transplant cyclophosphamide.

Im A, Wang T, DeFilipp Z, Farhadfar N, El Jurdi N, Khandelwal P, Kitko CL, Devos J, Castillo P, Ganguly S, Grunwald MR, Hamilton BK, Hashem H, Jamy O, Rangarajan HG, Kharfan-Dabaja MA, Yared JA, Williams KM, William BM, Spellman SR, Lee SJ, Pavletic S

PubMed
PMID: 42957810

Abstract
Related Articles

CIBMTR Study #: GV22-02

Working Committee: Graft-versus-Host Disease